文章摘要
治部真里,李颖.在研药物关联专利的判别指标[J].情报工程,2015,1(2):021-030
在研药物关联专利的判别指标
Refined Indicators for Patents Linked with Marketed Drugs and Pipelines
  
DOI:10.3772/j.issn.2095-915X.2015.02.003
中文关键词: 日本版NIH,药品,专利,指标,研究开发,低分子化合物,生物药,生物技术,循证政策,专利质量
英文关键词: Japanese version of the NIH, pharmaceuticals, patents, indicators, research and development, smallmolecules, bio-medicine, biotechnology, evidence based policy, patent quality
基金项目:“面向科技文献的日汉双向实用型机器翻译合作研究”(项目编号:2014DFA11350)
作者单位
治部真里 日本科学技术振兴机构 
李颖 中国科学技术信息研究所 
摘要点击次数: 1469
全文下载次数: 1587
中文摘要:
      日本版NIH及其制药企业,政策制定·战略规划需要佐证。本研究尝试基于新的指标体系对制药行业现状进行俯瞰与预测未来。连载第四篇,为了基于专利把握医药品产业的基础研究能力,定位与制药企业各个研发项目的进展状况【临床前实验】→【Ⅰ期临床试验】→【Ⅱ期临床试验】→【Ⅲ期临床试验】→【批准申请】→【批准】→【上市】密切相关的专利,尝试导出其新型指标。明确了作为指标,IPC分类、被引专利数、专利引用非专利文献数有效。基于专利的这些新指标,不但是通过在研药物(pipeline),也可以通过专利把握医药品产业新药创出力以及未来新药的创出力。
英文摘要:
      For the sake of providing evidences that contribute to policy making or strategy planning in a Japanese version of the NIH and pharmaceutical companies, we tried an overview and future prospects of pharmaceutical industry based on new indicators. Here we show new indicators for identifying patents related with pharmaceutical entities' R&D progress (“Pre-clinical” →“Phase 1” →“Phase 2” →“Phase 3” →“Filed” →“Approved” →“Marketed”). “IPC Count”, “Backward Citations”, and “Citations to Non-Patent Literature” found as new indicators. Not only pipelines but also patents extracted by new indicators are considered to forecast pharmaceutical industries’ power of creating new drugs.
查看全文   查看/发表评论  下载PDF阅读器
关闭

分享按钮